MAPK3 and cardiac hypertrophy: On the one hand ERK1/2 activity is thought to be involved in development of cardiac hypertrophy while on the other hand ERK1/2 signaling might have beneficial effects on abnormal healing and cardiac dysfunction via regulation of Fibroblast growth factor 21 (FGF21) signaling39.